1. Home
  2. NCNA vs OPI Comparison

NCNA vs OPI Comparison

Compare NCNA & OPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCNA
  • OPI
  • Stock Information
  • Founded
  • NCNA 1997
  • OPI 2009
  • Country
  • NCNA United Kingdom
  • OPI United States
  • Employees
  • NCNA N/A
  • OPI N/A
  • Industry
  • NCNA Biotechnology: Pharmaceutical Preparations
  • OPI Real Estate Investment Trusts
  • Sector
  • NCNA Health Care
  • OPI Real Estate
  • Exchange
  • NCNA Nasdaq
  • OPI Nasdaq
  • Market Cap
  • NCNA 15.4M
  • OPI 16.6M
  • IPO Year
  • NCNA 2017
  • OPI 2009
  • Fundamental
  • Price
  • NCNA $3.44
  • OPI $0.22
  • Analyst Decision
  • NCNA Buy
  • OPI
  • Analyst Count
  • NCNA 2
  • OPI 0
  • Target Price
  • NCNA $5,000.00
  • OPI N/A
  • AVG Volume (30 Days)
  • NCNA 733.3K
  • OPI 596.9K
  • Earning Date
  • NCNA 08-20-2025
  • OPI 07-30-2025
  • Dividend Yield
  • NCNA N/A
  • OPI 17.95%
  • EPS Growth
  • NCNA N/A
  • OPI N/A
  • EPS
  • NCNA N/A
  • OPI N/A
  • Revenue
  • NCNA N/A
  • OPI $466,972,000.00
  • Revenue This Year
  • NCNA N/A
  • OPI N/A
  • Revenue Next Year
  • NCNA N/A
  • OPI N/A
  • P/E Ratio
  • NCNA N/A
  • OPI N/A
  • Revenue Growth
  • NCNA N/A
  • OPI N/A
  • 52 Week Low
  • NCNA $3.05
  • OPI $0.18
  • 52 Week High
  • NCNA $1,856.00
  • OPI $2.48
  • Technical
  • Relative Strength Index (RSI)
  • NCNA 30.79
  • OPI 42.18
  • Support Level
  • NCNA $3.05
  • OPI $0.23
  • Resistance Level
  • NCNA $3.78
  • OPI $0.25
  • Average True Range (ATR)
  • NCNA 0.82
  • OPI 0.01
  • MACD
  • NCNA 0.11
  • OPI -0.00
  • Stochastic Oscillator
  • NCNA 5.61
  • OPI 12.00

About NCNA NuCana plc

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.

About OPI Office Properties Income Trust of Beneficial Interest

Office Properties Income Trust is a United States-based real estate investment trust. Its property portfolio is mainly composed of single-tenant office buildings, as well as multitenant properties, which are leased to parties of high credit quality characteristics. Its major tenant is the U.S. government, followed by other smaller government entities and corporations. The company's properties are spread across the United States. The company has only one segment which is direct ownership of real estate properties.

Share on Social Networks: